Understanding the burden of invasive pneumococcal disease attributable to serotype 3 in older adults in Europe, the United States, and Australia, and the potential of MAPS technology-based pneumococcal vaccines

Cell Reports · Elsevier

Аннотация

Publication date: December 2026 Source: Vaccine: X, Volume 33 Author(s): Stephanie Volpe, Emmanuel Aris, Taylor C. Stevenson, Shite Sebastian, Richard Malley, Michele Pellegrini

Читать у издателя →

Похожие статьи